Title : Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB Alterations.

Pub. Date : 2016 Jun 20

PMID : 27044931






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSION: Afatinib demonstrated significant activity in patients with platinum-refractory UC with HER2 or ERBB3 alterations. Platinum erb-b2 receptor tyrosine kinase 2 Homo sapiens